Addressing Disparities in Autism Spectrum Disorder Diagnosis Using a Direct-to-home Telemedicine Tool

The investigators propose to evaluate the use of a telemedicine tool, the TELE-ASD-PEDS (TAP), that is designed to assess for autism spectrum disorder (ASD) symptoms in toddlers. The TAP was developed at VUMC by a team of clinical psychologists with expertise in the early identification of ASD. The TAP has been studied in controlled laboratory settings, with high levels of family and clinician satisfaction, as well as excellent agreement with blinded comprehensive ASD evaluation. The TAP has also been used to complete direct-to-home telemedicine assessments during the COVID-19 pandemic. However, the investigators have not yet compared direct-to-home assessments using the TAP with gold standard, in-person ASD assessments. It has also not yet been studied in a diverse sample of families or with providers outside of VUMC. This study will allow the investigators to address those gaps.

NCT Number	NCT05047224
Lead Sponsor	Vanderbilt University Medical Center Collaborators: National Institute of Mental Health (NIMH)
Conditions	Autism Spectrum Disorder
Enrollment	664 participants
Start Date	2021-12-03
Primary Completion	2026-03-10 (estimated)
Study Completion	2026-07-06 (estimated)
Updated on ClinicalTrials.gov	2026-08-12